EMEA-002146-PIP02-18

Key facts

Invented name
Ibrance
Active substance
palbociclib
Therapeutic area
Oncology
Decision number
P/0005/2019
PIP number
EMEA-002146-PIP02-18
Pharmaceutical form(s)
  • Capsule, hard
  • Age-appropriate oral dosage form
  • Tablet
Condition(s) / indication(s)
Treatment of breast malignant neoplasms
Route(s) of administration
Oral use
Contact for public enquiries
Pfizer Europe MA EEIG

Tel. +44 1304 6466 07
E-mail: PIP_Enquiries@pfizer.com

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating